GRC Stock Analysis: Gorman-Rupp | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 2.423m USD | 12M Return: 120% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.0M
EPS Trend: 98.3%
Qual. Beats: 2
Rev. Trend: 94.0%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Gorman-Rupp Company (NYSE: GRC) is a U.S.-based manufacturer of pumps and pump systems, selling both domestically and internationally. Founded in 1933 and headquartered in Mansfield, Ohio, the company produces a broad portfolio that includes self-priming centrifugal, standard centrifugal, magnetic drive, axial/mixed flow, vertical turbine, submersible, rotary gear, diaphragm, and bellows pumps, among others. These products serve a wide range of end markets such as water, wastewater, construction, industrial, petroleum, chemical processing, agriculture, fire suppression, HVAC, and military liquid-handling applications.
The company operates within the Industrials sector (GICS Sub Industry: Industrial Machinery & Supplies & Components) and reaches customers through a diversified multi-channel sales model, including distributors, manufacturers representatives, third-party catalogs, direct sales, retailers, and e-commerce. This combination of a varied product line, exposure to both infrastructure-related and industrial end markets, and a multi-channel distribution approach is typical of established mid-cap industrial machinery suppliers, and supports demand across both economic and municipal water spending cycles.
- Federal infrastructure spending lifts water and wastewater pump orders
- Defense and military pump revenue grows on elevated government spending
- Steel and copper input costs pressure pump manufacturer margins
| Net Income: 58.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.49 > 1.0 |
| NWC/Revenue: 22.68% < 20% (prev 19.81%; Δ 2.87% < -1%) |
| CFO/TA 0.12 > 3% & CFO 107.1m > Net Income 58.7m |
| Net Debt (262.9m) to EBITDA (125.7m): 2.09 < 3 |
| Current Ratio: 2.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.3m) vs 12m ago 0.35% < -2% |
| Gross Margin: 29.77% > 18% (prev 31.05%; Δ -1.28% > 0.5%) |
| Asset Turnover: 80.83% > 50% (prev 77.44%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: 4.44 > 6 (EBIT TTM 97.9m / Interest Expense TTM 22.1m) |
| A: 0.18 (Total Current Assets 239.2m - Total Current Liabilities 81.5m) / Total Assets 861.9m |
| B: 0.50 (Retained Earnings 431.7m / Total Assets 861.9m) |
| C: 0.11 (EBIT TTM 97.9m / Avg Total Assets 859.9m) |
| D: 0.98 (Book Value of Equity 425.6m / Total Liabilities 436.3m) |
| Altman-Z'' = 4.62 = AA |
| DSRI: 1.04 (Receivables 102.1m/93.5m, Revenue 695.0m/664.3m) |
| GMI: 1.04 (GM 31.05% / 29.77%) |
| AQI: 0.97 (AQ_t 0.57 / AQ_t-1 0.59) |
| SGI: 1.05 (Revenue 695.0m / 664.3m) |
| TATA: -0.06 (NI 58.7m - CFO 107.1m) / TA 861.9m) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of July 04, 2026, the stock is trading at USD 84.06 with a total of 260,200 shares traded. Over the past week, the price has changed by -7.47%, over one month by +10.62%, over three months by +34.12% and over the past year by +119.97%.
Current recommended Stop Loss: 80.40 (which is 4.4% or 1.2 ATR below the current price).
Gorman-Rupp has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy GRC.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 75 | -10.8% |
P/E Trailing = 40.9554
P/E Forward = 35.3357
P/S = 3.486
P/B = 5.6928
P/EG = 2.7142
Revenue TTM = 695.0m USD
EBIT TTM = 97.9m USD
EBITDA TTM = 125.7m USD
Long Term Debt = 292.8m USD (from longTermDebt, last quarter)
Short Term Debt = 24.6m USD (from shortTermDebt, last fiscal year)
Debt = 292.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 262.9m USD (calculated: Debt 292.8m - CCE 29.9m)
Enterprise Value = 2.69b USD (2.42b + Debt 292.8m - CCE 29.9m)
Interest Coverage Ratio = 4.44 (Ebit TTM 97.9m / Interest Expense TTM 22.1m)
EV/FCF = 30.35x (Enterprise Value 2.69b / FCF TTM 88.5m)
FCF Yield = 3.30% (FCF TTM 88.5m / Enterprise Value 2.69b)
FCF Margin = 12.73% (FCF TTM 88.5m / Revenue TTM 695.0m)
Net Margin = 8.45% (Net Income TTM 58.7m / Revenue TTM 695.0m)
Gross Margin = 29.77% ((Revenue TTM 695.0m - Cost of Revenue TTM 488.1m) / Revenue TTM)
Gross Margin QoQ = 30.74% (prev 29.57%)
Tobins Q-Ratio = 3.12 (Enterprise Value 2.69b / Total Assets 861.9m)
Interest Expense / Debt = 7.53% (Interest Expense 22.1m / Debt 292.8m)
Taxrate = 22.60% (17.2m / 75.9m)
NOPAT = 75.8m (EBIT 97.9m * (1 - 22.60%))
Current Ratio = 2.93 (Total Current Assets 239.2m / Total Current Liabilities 81.5m)
Debt / Equity = 0.69 (Debt 292.8m / totalStockholderEquity, last quarter 425.6m)
Debt / EBITDA = 2.09 (Net Debt 262.9m / EBITDA 125.7m)
Debt / FCF = 2.97 (Net Debt 262.9m / FCF TTM 88.5m)
Total Stockholder Equity = 410.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.83% (Net Income 58.7m / Total Assets 861.9m)
RoE = 14.30% (Net Income TTM 58.7m / Total Stockholder Equity 410.8m)
RoCE = 13.92% (EBIT 97.9m / Capital Employed (Equity 410.8m + L.T.Debt 292.8m))
RoIC = 9.78% (NOPAT 75.8m / Invested Capital 775.1m)
WACC = 8.80% (E(2.42b)/V(2.72b) * Re(9.16%) + D(292.8m)/V(2.72b) * Rd(7.53%) * (1-Tc(0.23)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.61 | Cagr: 0.25%
[DCF] Terminal Value 76.52% ; FCFF base≈79.8m ; Y1≈91.5m ; Y5≈134.6m
[DCF] Fair Price = 61.12 (EV 1.88b - Net Debt 262.9m = Equity 1.61b / Shares 26.4m; r=8.80% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.29 | EPS CAGR: 31.99% | SUE: 3.21 | # QB: 2
Revenue Correlation: 94.03 | Revenue CAGR: 2.72% | SUE: 1.83 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.62 | Chg30d=+0.00% | Revisions=+20% | Analysts=2
EPS current Year (2026-12-31): EPS=2.63 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+23.1% | GrowthRev=+5.7%
EPS next Year (2027-12-31): EPS=3.00 | Chg30d=+1.47% | Revisions=+20% | GrowthEPS=+13.8% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +20%